Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics

Shiu, Jr-Shiang; Hsieh, Ming-Ju; Chiou, Hui-Ling; Wang, Hsiang-Ling; Yeh, Chao-Bin; Yang, Shun-Fa; Chou, Ying-Erh

doi:10.7150/ijms.27059



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2018; 15(12):1334-1340. doi:10.7150/ijms.27059 This issue Cite

Research Paper

Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics

Jr-Shiang Shiu¹, Ming-Ju Hsieh^2,3,4, Hui-Ling Chiou^5,6, Hsiang-Ling Wang⁷, Chao-Bin Yeh^8,9, Shun-Fa Yang^2,10, Ying-Erh Chou^8,10,✉

1. Department of Emergency Medicine, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan
2. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
3. Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan
4. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
5. School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan
6. Department of Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan
7. Department of Beauty Science, National Taichung University of Science and Technology, Taichung, Taiwan
8. School of Medicine, Chung Shan Medical University, Taichung, Taiwan
9. Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
10. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan

Citation:

Shiu JS, Hsieh MJ, Chiou HL, Wang HL, Yeh CB, Yang SF, Chou YE. Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics. Int J Med Sci 2018; 15(12):1334-1340. doi:10.7150/ijms.27059. https://www.medsci.org/v15p1334.htm

Other styles

Abstract

A disintegrin and metalloprotease (ADAM) family proteins are type-I transmembrane glycoproteins with multiple functions in cell adhesion, migration, proteolysis and signaling. ADAM10 is a member of the ADAM family reportedly involved in cancer progression and has been shown to be overexpressed in hepatocellular carcinoma (HCC) tissues and significantly associated with tumor progression and shortened survival. This study investigated ADAM10's single nucleotide polymorphisms (SNPs) and their association to HCC development and regulation. Real-time polymerase chain reaction was used to analyze five SNPs of ADAM10 in 333 patients with HCC and 1196 controls without cancer. The results indicated that of the 333 patients with HCC, those who carried ADAM10 rs514049 (AC + CC) variants had a higher risk of developing lymph node metastasis (odds ratio [OR] = 5.087, p = 0.027), and those who carried ADAM10 rs653765 (GA + AA) variants had a higher risk of developing distant metastasis (OR = 3.346, p = 0.020) and higher levels of α-fetoprotein. In conclusion, our study demonstrated that the SNPs of ADAM10 are involved in HCC progression. ADAM10 SNPs may be used as therapeutic targets to evaluate poor prognoses for HCC.

Keywords: Hepatocellular carcinoma, A disintegrin and metalloprotease 10, polymorphism

Citation styles

APA

Shiu, J.S., Hsieh, M.J., Chiou, H.L., Wang, H.L., Yeh, C.B., Yang, S.F., Chou, Y.E. (2018). Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics. International Journal of Medical Sciences, 15(12), 1334-1340. https://doi.org/10.7150/ijms.27059.

ACS

Shiu, J.S.; Hsieh, M.J.; Chiou, H.L.; Wang, H.L.; Yeh, C.B.; Yang, S.F.; Chou, Y.E. Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics. Int. J. Med. Sci. 2018, 15 (12), 1334-1340. DOI: 10.7150/ijms.27059.

NLM

CSE

Shiu JS, Hsieh MJ, Chiou HL, Wang HL, Yeh CB, Yang SF, Chou YE. 2018. Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics. Int J Med Sci. 15(12):1334-1340.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.